PARENTS of overweight kids have welcomed the news that a major study has found that fat jabs are safe for children. But ...

Chronic inflammation can cause damage to the lining of the intestine. Read on to know about 7 symptoms that point towards that.

Novo Nordisk's lawsuit seeks a permanent injunction forcing Eli Lilly to pull the ads, as well as a corrective ad campaign.

As GLP-1 drug use surges nationwide, overall spending could soon drive up healthcare costs for everyone, according to a new study.

A new study reveals how next generation GIPR drugs act on the brainstem and hypothalamus to boost weight loss.

Pharmaceutical contractor’s GLP-1 programmes and surging stock gains have made it a magnet for global investors.

Novo Nordisk, the maker of Ozempic, is suing Eli Lilly over advertisements comparing some of their biggest-selling drugs. The ads compare Lilly’s Zepbound with Novo’s Wegovy, and Novo argues they give ...

Retatrutide just took a major step in its journey toward FDA approval. Eli Lilly, the company that makes retatrutide, ...

Novo says Lilly's ads for Zepbound and Mounjaro rely on outdated data and omit newer, higher-dose versions of Wegovy and ...

Cambridge scientists have solved the mystery of why both stimulating and blocking a particular 'switch' in the brain can help people lose weight – findings which could help boost the effectiveness of ...

Novo Nordisk, through its drugs Ozempic and Wegovy, and Eli Lilly are competing to control the nearly $80 billion weight-loss drug market. How much weight a drug helps patients lose is a key ...

Cambridge scientists have solved the mystery of why both stimulating and blocking a particular ‘switch’ in the brain can help ...